Literature DB >> 20422899

Clinicopathological features of undifferentiated mixed type early gastric cancer treated with endoscopic submucosal dissection.

Junichi Iwamoto1, Yuji Mizokami, Masanori Ito, Koichi Shomokobe, Takeshi Hirayama, Akira Honda, Yoshifumi Saito, Tadashi Ikegami, Yasushi Matsuzaki.   

Abstract

BACKGROUND/AIMS: Previous published data on the differentiated/undifferentiated mixed-type early gastric cancer treated with ESD are scarce.
METHODOLOGY: The clinicopathological features of the pure differentiated type and differentiated/undifferentiated mixed type adenocarcinoma in final diagnosis of ESD specimens were investigated in 109 early gastric cancers patients treated with ESD.
RESULTS: Of the pure differentiated type (102 patients) and differentiated / undifferentiated mixed type (7 patients) adenocarcinoma, submucosal invasive tumors were detected in 6 (5.9%) and 4 cases (57.1%) (p = 0.017), respectively. The mean tumor size was 10.95 +/- 5.12mm and 22.85 +/- 9.51mm (p = 0.0091), respectively. In the cases diagnosed as moderately differentiated adenocarcinoma by preoperative ESD biopsy, submucosal invasive tumors were detected in 2 (12.5%) and 4 cases (57.1%) (p = 0.038), respectively, and the mean tumor size was 12.50 +/- 5.88mm and 22.85 +/- 9.51mm (p = 0.016), respectively. During a median follow-up period of 30.3 months (range: 7-52 months), there were no recurrences or metastasis in any of the 7 mixed type cases.
CONCLUSION: In conclusion, the results of our study suggest that large gastric tumors treated with ESD which are diagnosed as moderately differentiated adenocarcinoma in biopsy specimens potentially contain an undifferentiated component.

Entities:  

Mesh:

Year:  2010        PMID: 20422899

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  7 in total

1.  Endoscopic Submucosal Dissection of Early Gastric Cancer with Mixed-Type Histology: A Systematic Review.

Authors:  Chang Seok Bang; Young Joo Yang; Jae Jun Lee; Gwang Ho Baik
Journal:  Dig Dis Sci       Date:  2019-07-31       Impact factor: 3.199

2.  Histological mixed-type as an independent prognostic factor in stage I gastric carcinoma.

Authors:  Shuhei Komatsu; Daisuke Ichikawa; Mahito Miyamae; Hiroki Shimizu; Hirotaka Konishi; Atsushi Shiozaki; Hitoshi Fujiwara; Kazuma Okamoto; Mitsuo Kishimoto; Eigo Otsuji
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

3.  Risk factors for submucosal and lymphovascular invasion in gastric cancer looking indicative for endoscopic submucosal dissection.

Authors:  Takeshi Yamada; Hiroaki Sugiyama; Daisuke Ochi; Daisuke Akutsu; Hideo Suzuki; Toshiaki Narasaka; Toshikazu Moriwaki; Shinji Endo; Tsuyoshi Kaneko; Kaishi Satomi; Kazuto Ikezawa; Yuji Mizokami; Ichinosuke Hyodo
Journal:  Gastric Cancer       Date:  2013-12-10       Impact factor: 7.370

4.  Discrepancies in the histologic type between biopsy and resected specimens: a cautionary note for mixed-type gastric carcinoma.

Authors:  Shuhei Komatsu; Daisuke Ichikawa; Mahito Miyamae; Toshiyuki Kosuga; Hirotaka Konishi; Atsushi Shiozaki; Hitoshi Fujiwara; Kazuma Okamoto; Mitsuo Kishimoto; Eigo Otsuji
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

5.  Liver Metastasis of Early Gastric Cancer with Mixed Histology after Endoscopic Submucosal Dissection.

Authors:  Yang Hee Han; Jong Kyu Park; Jun Sung Kwon; Young Don Kim; Woo Jin Jeong; Sang Jin Lee; Koon Hee Han; Gab Jin Cheon
Journal:  Clin Endosc       Date:  2015-05-29

6.  Risk Factors of Submucosal or Lymphovascular Invasion in Early Gastric Cancer <2 cm.

Authors:  Yu Yi Choi; Su Jin Kim; Cheol Woong Choi; Dae Hwan Kang; Hyung Wook Kim; Su Bum Park; Hyeong Seok Nam
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

7.  Predictive factors to diagnosis undifferentiated early gastric cancer after endoscopic submucosal dissection.

Authors:  Dae G Ryu; Cheol W Choi; Dae H Kang; Hyung W Kim; Su B Park; Su J Kim; Hyeong S Nam
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.